CASDIN CAPITAL, LLC – Blueprint Medicines Corporation Transaction History
CASDIN CAPITAL, LLC portfolio value:
$112.01M
portfolio value
CASDIN CAPITAL, LLC quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +47.83% | 550K shares | 53.92M | $65.89 | 1.7M |
| Q2 2022 | share | Decrease | -25.81% | -400K shares | -40.92M | $50.51 | 1.15M |
| Q1 2022 | share | 0.00% | 0 shares | -67.00M | $63.88 | 1.55M | |
| Q4 2021 | share | 0.00% | 0 shares | 6.66M | $109.45 | 1.55M | |
| Q3 2021 | share | 0.00% | 0 shares | 23.01M | $102.81 | 1.55M | |
| Q2 2021 | share | 0.00% | 0 shares | -14.36M | $87.96 | 1.55M | |
| Q1 2021 | share | 0.00% | 0 shares | -23.12M | $97.23 | 1.55M | |
| Q4 2020 | share | 0.00% | 0 shares | 30.14M | $112.15 | 1.55M | |
| Q3 2020 | share | 0.00% | 0 shares | 22.78M | $92.7 | 1.55M | |
| Q2 2020 | share | 0.00% | 0 shares | 30.25M | $78 | 1.55M | |
| Q1 2020 | share | Increase | +64.89% | 610K shares | 15.34M | $58.48 | 1.55M |
| Q4 2019 | share | 0.00% | 0 shares | 6.24M | $80.11 | 940K | |
| Q3 2019 | share | 0.00% | 0 shares | -19.60M | $73.47 | 940K | |
| Q2 2019 | share | Increase | +10.76% | 91.35K shares | 20.73M | $94.33 | 940K |
| Q1 2019 | share | Increase | +32.60% | 208.64K shares | 33.43M | $80.05 | 848.64K |
| Q4 2018 | share | Decrease | -14.67% | -110K shares | -24.04M | $53.91 | 640K |
| Q3 2018 | share | Increase | +18.11% | 115K shares | 18.23M | $78.06 | 750K |
| Q3 2018 | call | Decrease | -100.00% | -10K shares | -635K | $78.06 | 0 |
| Q2 2018 | call | Increase | 0.00% | 10K shares | 635K | $63.48 | 10K |
| Q2 2018 | share | Increase | +82.47% | 287K shares | 8.39M | $63.48 | 635K |
| Q1 2018 | share | 0.00% | 0 shares | 5.66M | $91.7 | 348K | |
| Q4 2017 | share | Increase | +16.78% | 50K shares | 5.48M | $75.41 | 348K |
| Q3 2017 | share | Increase | +8.36% | 23K shares | 6.82M | $69.67 | 298K |
| Q2 2017 | share | Decrease | -6.62% | -19.5K shares | 2.15M | $50.67 | 275K |
| Q1 2017 | share | Increase | +20.45% | 50K shares | 4.91M | $39.99 | 294.5K |
| Q4 2016 | share | Decrease | -14.81% | -42.5K shares | -1.66M | $28.05 | 244.5K |
| Q3 2016 | share | Decrease | -15.59% | -53K shares | 1.63M | $29.7 | 287K |
| Q2 2016 | share | Increase | +5.82% | 18.7K shares | 1.08M | $20.25 | 340K |
| Q1 2016 | share | Decrease | -22.11% | -91.2K shares | -5.06M | $18.05 | 321.3K |